Skip to content
Subscriber Only

U.K. to Brief on AstraZeneca Vaccine as Safety Concerns Grow

  • Briefing by medicines regulator scheduled for Wednesday 3 p.m.
  • Moderna doses offered in U.K. alongside AstraZeneca and Pfizer
Bloomberg business news
Noubar Afeyan, co-founder of Moderna, says the company is targeting Covid variants.Source: Bloomberg)
Updated on

The U.K.’s drug regulator will address safety concerns surrounding AstraZeneca Plc’s Covid-19 vaccine on Wednesday, as fears grow that the government’s inoculation targets will be put at risk.

Representatives from the U.K.’s Medicines and Healthcare products Regulatory Agency and the government’s vaccine committee will speak at 3 p.m., at the same time as the European Medicines Agency holds its own press briefing.